Cyclin dependent kinase 4/6 inhibitors in early breast cancer: what is the role of Ki-67?

Authors :: Gabriele, Antonarelli
Carmine, Valenza
Erica L, Mayer
Sibylle, Loibl
Giuseppe, Curigliano
Source :: The Lancet Oncology. 23:325-328
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Clinical Trials as Topic
Ki-67 Antigen
Oncology
Biomarkers, Tumor
Cyclin-Dependent Kinase 4
Humans
Breast Neoplasms
Female
Cyclin-Dependent Kinase 6
Protein Kinase Inhibitors
Risk Assessment

Full Text Access

Tools